Direct PeptidesProduct page includes use or preparation wordingIn stock
MOTS-c · 10 mg × 10 vials
$439.00$4.39 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
MOTS-c research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 10 mg × 10 vials$4.39 / mg · $439.00Direct Peptides · checked 5 days ago
Listings at 10 mg × 10 vials
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Direct PeptidesProduct page includes use or preparation wording | 10 mg × 10 vials | $439.00 | $4.39 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for MOTS-c. Current means seen in the last 8 days.
| 5 mg × 1 vial | $59.99 | $12.00 / mg | 1 / 1 | 1 |
|---|---|---|---|---|
| 10 mg × 1 vial | $30.00 | $3.00 / mg | 13 / 13 | 12 |
| 20 mg × 1 vial | $110.00 | $5.50 / mg | 1 / 3 | 1 |
| 40 mg × 1 vial | $80.00 | $2.00 / mg | 6 / 7 | 6 |
| 10 mg × 10 vials | $439.00 | $4.39 / mg | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Named in a draft HHS enforcement-discretion policy (2026-10-30) covering MOTS-c acetate in subcutaneous or intramuscular injectable forms only; not an approval or a 503A listingChecked
- Advisory committee (PCAC)
- PCAC discussed MOTS-c and its acetate on 2026-07-23 (uses reviewed: obesity, osteoporosis); FDA's briefing weighed against listing. HHS says the PCAC voted in favor; no FDA vote record by 2026-11-03Checked
- Rulemaking / enforcement
- HHS notice of a draft peptide enforcement-discretion policy published 2026-10-30 (comments for 2 weeks); no proposed or final 503A rule on MOTS-c found (search on 2026-11-03)Checked
- WADA
- S4.4.1 Metabolic modulators: activators of AMP-activated protein kinase (AMPK) · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
- Human studies
- None recorded
- Identity
- Formula C101H152N28O22S2 · MW 2174.6 g/mol · CAS 1627580-64-6Sequence MRWQEMGYIFYPRKLRSource record Checked
Read the guide:MOTS-c: What Is Being Studied?
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.